Aligos Therapeutics, Inc. earnings per share and revenue

ALGS earnings per share for the last quarter are -3.07 USD whereas the estimation was -2.16 USD which accounts for -42.35% surprise. Company revenue for the same period amounts to 1.27 M USD despite the estimated figure of 333.33 k USD. Estimated earnings per share for the next quarter are -2.50 USD, and revenue is expected to reach 433.33 k USD. Also watch annual changes over time to get a bigger picture of ALGS earnings per share and revenue dynamics.